Skip to main content
Fig. 7 | BMC Cancer

Fig. 7

From: Efficacy of bevacizumab combined with chemotherapy in the treatment of HER2-negative metastatic breast cancer: a network meta-analysis

Fig. 7

Funnel plots of the publication bias tests for direct comparisons of progression-free survival (PFS) and overall response rates (ORR). A = Tax, C = Bev + Tax, D = Bev + Cap, G = Bev + Tax+Cap. Bev = bevacizumab, Cap = capecitabine, Tax = taxanes

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us